Top Markets
Coin of the day
OS Therapies Incorporated OS Therapies Incorporated

OS Therapies Incorporated

OSTX
Rangering i aksjer #23564
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses... OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
Aksjekurs
$1.58
Sist synkronisert: 2026-08-21
Markedsverdi
$71.95M
Endring (1 dag)
0.64%
Endring (1 år)
-36.29%
Land
US
Handel OS Therapies Incorporated (OSTX)

Kategori

EPS for OS Therapies Incorporated (OSTX)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til OS Therapies Incorporated er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for OS Therapies Incorporated fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH